2009-08-11

Strategic partnership to develop synthetic routes for chiral compounds

c-LEcta and Acoris Research, a wholly owned subsidiary of Hikal engaged in contract research enter into strategic partnership to develop synthetic routes for chiral compounds. The partnership combines the expertise of Acoris in Process Development and small scale manufacturing, and the unique biocatalysis technologies of c-LEcta. Acoris Research, based at the International Biotech Park in Pune, India has a state-of-the-art contract research facility and delivers contract research and manufacturing services to innovator companies.